Laseroptek레이저옵텍

Laseroptek's revenue and profits have shrunk sharply, with losses deepening and the share price down about 57% over the past year.

Laseroptek, a Korean maker of laser medical and beauty devices, reported trailing twelve-month revenue of ₩31.7B to H1 2026 against an operating loss of ₩10.4B. Revenue fell 22.2% in 2025 after a 3.8% drop in 2024, and the company has moved from a small profit in 2023 to sustained losses. The share price is ₩2,995, well below its 52-week high of ₩7,700.

What stands out

• Operating margin was -32.8% on a trailing basis and -46.9% for 2025, versus a 13% operating margin in 2023.
• Trailing free cash flow was -₩5.2B, and borrowings of ₩7.8B exceed cash of ₩9.8B.
• Valuation shows a price-to-book ratio of 1.5 and a price-to-sales ratio of 1.4, but no earnings-based multiples because earnings are negative; the data includes no fair value estimate.
• Foreign ownership fell from 3.4% to 1.6% over the past 60 days, and recent 20-day flows show net foreign selling with net retail buying.
• Recent filings are mostly insider and 5%+ holding reports, plus the H1 2026 half-year report filed on 14 August 2026; the news headline list is empty.

What to watch

• The next quarterly or annual filings, to see whether revenue stabilises and losses narrow from the H1 2026 trend.
• Changes in major shareholder and insider holdings, given the recent holding reports and foreign ownership decline.
• Debt and cash levels, since borrowings are close to cash while free cash flow is negative; the data does not describe any specific funding plans.